Clinical Trial Update: Lucica ® Glycated Albumin-L Clinical Program - Pivotal Study

View source ↗

Summary

Pivotal study update for the Lucica glycated albumin–L clinical program in diabetes; study completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus

Drugs mentioned

• Lucica (glycated albumin)

Snippet

Sponsor: Asahi Kasei Therapeutics Corporation | Conditions: Diabetes | Status: COMPLETED | Results posted: 2019-11-21